348 related articles for article (PubMed ID: 15975026)
1. The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implications.
Rozemuller AJ; van Gool WA; Eikelenboom P
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):223-33. PubMed ID: 15975026
[TBL] [Abstract][Full Text] [Related]
2. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
3. Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease.
Yin Z; Raj D; Saiepour N; Van Dam D; Brouwer N; Holtman IR; Eggen BJL; Möller T; Tamm JA; Abdourahman A; Hol EM; Kamphuis W; Bayer TA; De Deyn PP; Boddeke E
Neurobiol Aging; 2017 Jul; 55():115-122. PubMed ID: 28434692
[TBL] [Abstract][Full Text] [Related]
4. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
[TBL] [Abstract][Full Text] [Related]
5. T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer's disease-like cerebral amyloidosis.
Ferretti MT; Merlini M; Späni C; Gericke C; Schweizer N; Enzmann G; Engelhardt B; Kulic L; Suter T; Nitsch RM
Brain Behav Immun; 2016 May; 54():211-225. PubMed ID: 26872418
[TBL] [Abstract][Full Text] [Related]
6. Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits.
Scholtzova H; Do E; Dhakal S; Sun Y; Liu S; Mehta PD; Wisniewski T
J Neurosci; 2017 Jan; 37(4):936-959. PubMed ID: 28123027
[TBL] [Abstract][Full Text] [Related]
7. T-cells in Alzheimer's disease.
Town T; Tan J; Flavell RA; Mullan M
Neuromolecular Med; 2005; 7(3):255-64. PubMed ID: 16247185
[TBL] [Abstract][Full Text] [Related]
8. Aβ43 in human Alzheimer's disease: effects of active Aβ42 immunization.
Jäkel L; Boche D; Nicoll JAR; Verbeek MM
Acta Neuropathol Commun; 2019 Sep; 7(1):141. PubMed ID: 31477180
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation in Alzheimer's disease and prion disease.
Eikelenboom P; Bate C; Van Gool WA; Hoozemans JJM; Rozemuller JM; Veerhuis R; Williams A
Glia; 2002 Nov; 40(2):232-239. PubMed ID: 12379910
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
Carter CJ
Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models.
Wisniewski T; Boutajangout A
Brain Struct Funct; 2010 Mar; 214(2-3):201-18. PubMed ID: 20012091
[TBL] [Abstract][Full Text] [Related]
12. The potential importance of myeloid-derived suppressor cells (MDSCs) in the pathogenesis of Alzheimer's disease.
Salminen A; Kaarniranta K; Kauppinen A
Cell Mol Life Sci; 2018 Sep; 75(17):3099-3120. PubMed ID: 29779041
[TBL] [Abstract][Full Text] [Related]
13. Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity.
Bales KR; O'Neill SM; Pozdnyakov N; Pan F; Caouette D; Pi Y; Wood KM; Volfson D; Cirrito JR; Han BH; Johnson AW; Zipfel GJ; Samad TA
Brain; 2016 Feb; 139(Pt 2):563-77. PubMed ID: 26493635
[TBL] [Abstract][Full Text] [Related]
14. Neuroinflammatory perspectives on the two faces of Alzheimer's disease.
Eikelenboom P; van Gool WA
J Neural Transm (Vienna); 2004 Mar; 111(3):281-94. PubMed ID: 14991455
[TBL] [Abstract][Full Text] [Related]
15. Novel presenilin-1 mutation with widespread cortical amyloid deposition but limited cerebral amyloid angiopathy.
Yasuda M; Maeda S; Kawamata T; Tamaoka A; Yamamoto Y; Kuroda S; Maeda K; Tanaka C
J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):220-3. PubMed ID: 10644793
[TBL] [Abstract][Full Text] [Related]
16. 4Aβ1-15-Derived Monoclonal Antibody Reduces More Aβ Burdens and Neuroinflammation than Homologous Vaccine in APP/PS1 Mice.
Zhang Y; Zou J; Yang J; Yao Z
Curr Alzheimer Res; 2015; 12(4):384-97. PubMed ID: 25817256
[TBL] [Abstract][Full Text] [Related]
17. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
Baik SH; Kang S; Son SM; Mook-Jung I
Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
[TBL] [Abstract][Full Text] [Related]
18. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
19. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
[TBL] [Abstract][Full Text] [Related]
20. The significance of neuroinflammation in understanding Alzheimer's disease.
Eikelenboom P; Veerhuis R; Scheper W; Rozemuller AJ; van Gool WA; Hoozemans JJ
J Neural Transm (Vienna); 2006 Nov; 113(11):1685-95. PubMed ID: 17036175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]